Cómo citar
Osorio Carmona, E., & de Faria Rezende, C. M. (2014). Osteoartritits: aspectos clínicos y nuevas perspectivas terapéuticas basadas en la terapia regenerativa. Revista Veterinaria Y Zootecnia (On Line), 8(2), 49–71. Recuperado a partir de https://revistasojs.ucaldas.edu.co/index.php/vetzootec/article/view/4168

Autores/as

Esteban Osorio Carmona
Universidade Federal de Minas Gerais
freosorio105@gmail.com
Cleuza Maria de Faria Rezende
Universidade Federal de Minas Gerais
sincorreo@ucaldas.edu.co

Resumen

Resumen: Las enfermedades articulares en animales de pequeño porte representan un alto porcentaje en la rutina de los hospitales veterinarios. La alta frecuencia de lesiones articulares derivadas de diferentes factores (fracturas intraarticulares, ruptura de ligamentos, enfermedades predisponentes, entre otras) exige terapias más efectivas. El objetivo del tratamiento de las enfermedades articulares después de la corrección de las causas primarias es disminuir el dolor y retardar el avance de la osteoartritis. El equilibrio en el metabolismo del cartílago es de vital importancia para el mantenimiento de la integridad de la matriz extracelular y de las otras estructuras que forman el cartílago. El desequilibrio entre las citocinas y los factores de crecimiento puede llevar a alteraciones irreversibles e incapacitantes en la superficie articular de las principales articulaciones. La osteoartritis se caracteriza por la alteración de la estructura del cartílago articular, disminución de los movimientos articulares acompañado de crepitación, formación de osteófitos, claudicación, dolor y pérdida de la función. Los tratamientos disponibles en la actualidad incluyen los conservativos y quirúrgicos que tratan de estabilizar las articulaciones y aliviar el dolor, pero no prevenir la progresión de la enfermedad articular degenerativa. El plasma rico en plaquetas (PRP) es una sustancia autóloga obtenida a partir de la sangre total sometida a procesos de centrifugación y activación que han mostrado potencial terapéutico en el tratamiento de algunas enfermedades y en diversas áreas de la medicina humana y veterinaria. El objetivo de esta presentación bibliográfica es revisar los principales aspectos de la osteoartritis, el papel de las citocinas en el desarrollo de esta, las características del plasma rico en plaquetas, procesos de obtención y su uso como nueva alternativa terapéutica en las principales lesiones articulares que afectan a los animales domésticos.

Anitua, E.; Andia, I.; Sanchez, M. et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.Journal of Orthopaedic Research, v.23, p.281‐286, 2005.

Anitua, E.; Prado, R.; Sanchez, M. et al. Platelet‐rich plasma: Preparation and formulation. Operative techniques in orthopaedics ,v.22, p.25‐32, 2012.

Anitua, E.; Sanchez, M.; Zaldueno, M.M. et al. Fibroblastic response to PRGF treatment fibroblastic response to treatment with different preparations rich in growth factors. Cell proliferation, v.42,p.162‐170, 2009.

ANVISA. Nota técnica,n.34, Brasília:Agencia nacional de vigilância sanitária,2012. 5p.

Arend, W.P.; Dayer, J.M. Cytokines and growth factors. In: Kelley, W.N.; Harris, E.D.; Ruddy, S. et al (Ed).Textbook of Rheumatology. Philadelphia: Saunders, 1993.p. 227‐ 247.

Argüelles, D.; Carmona, J.U.; Pastor, J. et al. Evaluation of single and double centrifugation tube methodsfor concentrating equine platelets. Research in Veterinary Science, v.81, p.237‐245, 2006.

Arnold, J.A.; Coker, T.P.; Heaton, L.M. et al. Natural history of anterior cruciatetears. American Journal of Sports Medicine, v.7, p.305‐313, 1979.

Ayral,X.; Pickering, E.H.; Woodworth, T.G. et al. Synovitis: Apotential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis. Results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage, v. 13, p. 361‐ 367, 2005.

Baksh, N.; Hannon, C.; Murawski, C. et al. Platelet‐rich plasma in tendon models: A systematic review of basic science literature. The Journal of Arthroscopic and Related Surgery, v.29, n.3, p.596‐607, 2013.

Beca, T.; Hernandez, G.; Morante, S. et al. Plasma rico en plaquetas. Una revisión bibliográfica. Avances en Periodoncia e Implantología Oral, v.19, n.1, p.39‐52, 2007.

Behnke,O.;Forer, A. From megakaryocytes to platelets: Platelet morphogenesis takes place in the bloodstream. European Journal of Haematology, .60,p.3‐24, 1998.

Bennett, N.T.; Schultz, G.S. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. The American Journal of Surgery, v.166, n.1, p.74‐81, 1993.

Bergmeier, W.; Stefanini, L. Novel molecules in calcium signaling in platelets. Journal of Thrombosis e Haemostasia, v.7, p.E187‐E190, 2009 (suppl.1).

Blair, P.; Flaumenhaft, R. Platelet α‐granules: Basic biology and clinical correlates. Blood Reviews, v.23,p. 177‐189, 2009.

Blom, A.B.; Van Lent, P.L.; Libregts, S. et al. Crucial role of macrophages in matrix metalloproteinase‐mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis & Rheumatism, v. 56, p.147‐157, 2007.

Bolon, B.; Campagnuolo, G.; Zhu, L. et al. Interleukin‐1beta and tumor necrosis factor‐ alpha produce distinct, time‐dependent patterns of acute arthritis in the rat knee. Veterinary Pathology, v.41, n.3, p.235‐243, 2004.

Boswell, S.G.; Cole, B.J.; Sundman, E.A. et al. Platelet‐rich plasma: A milieu of bioactive factors. The Journal of Arthroscopic and Related Surgery, v.28, n.3, p.429‐439, 2012.

Boudreaux, M.; Osborne, C.D.; Herre, A.C. et al. Unique structure of the M loop region of b1‐tubulin may contribute to size variability of platelets in the family Felidae. Veterinary Clinical Pathology, v.39, n.4, p.417‐423, 2010.

Brandt, K.D.; Dieppe, P.; Radin, E.L. Commentary: Is it useful to subset “primary” osteoarthritis? A critique based on evidence regarding the oetiopathogenesis of osteoarthritis. Seminars in Arthritis and Rheumatism, v.39, p.81‐95, 2009.

Brennan, F.M.; Maini, R.N.; Feldmann, M. Role of pro‐inflammatory cytokines in rheumatoid arthritis. Springer Seminars in Immunopathology, v.20, p.133‐147, 1998.

Broughton II, G.; Janis, J.E.; Attinger, C.E. Wound healing: An overview. Plastic and Reconstructive Surgery, v.117, p.E1‐E32, 2006 (suppl.7).

Broughton II, G.; Janis, J.E.; Attinger, C.E. The Basic Science of Wound Healing. Plastic and Reconstructive Surgery, v.117, p.E12‐34S, 2006 (suppl.7).

Buckwalter, J.A.; Mankin,H.J.Articular cartilage: Degeneration and osteoarthritis, repair, regeneration, and transplantation. Instructional Course Lectures, v.47, p.487‐ 504, 1998.

Canapp, D. Canine osteoarthritis. Clinician’s brief, p. 21‐23, 2013.

Carmona, J.U. Use of autologous platelet concentrates for the treatment of musculoskeletal injuries in the horse. Preliminary clinical studies and cellular and molecular evaluation of equine platelet concentrates obtained by single and double centrifugation tube methods. Bellaterra, Espanha: Universitat Autonoma de Barcelona, 2006. 100p. Tese (Doutorado em medicina veterinaria).

Carmona, J.U.; Lopez, C. Autologous platelet concentrates as a treatment for shoulder injury in a horse.Case report. Journal of Equine Veterinary Science, v.31, p.506‐510, 2011.

Carrasco, J.; Bonete, D.; Gomar, F. Plasma rico en plaquetas vs. Plasma rico en factores de crecimiento. Revista Española de Cirugía Osteoarticular, v.46, n.239, p.127‐140, 2009.

Carter, S.D.; Barnes, A.; Gilmore, W.H. Canine rheumatoid arthritis and inflammatory cytokines. Veterinary Immunology and Immunopathlogy, v.69, p.201‐214, 1999.

Chang, S.K.; Egami, D.K.; Shaieb, M.D. et al. Anterior cruciate ligament reconstruction: Allograft versus autograft. Arthroscopy: The Journal of Arthroscopic and Related Surgery, v.19, p.453‐462, 2003.

Choi, B.H.; Zhu, S.J.; Kim, B.Y. et al. Effect of platelet‐rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: An in vitro study. International Journal of Oral and Maxillofacial Surgery, v.34, p.420‐424, 2005.

Clark, T.P. The clinical pharmacology ofciclooxigenase‐2‐selective and dual inhibitors. Veterinary Clinics of North America Small Animal Practice, v. 36, p. 1061‐1085. 2006.

Codesido, P.; Leyes, M.; Forriol, F. Relationship between mechanism of injury and associated lesions in anterior cruciate ligament tears. Revista Española de Cirugía Ortopédica y Traumatología, v.53, n.4, p.231‐236, 2009.

Coughlan, A.R.; Robertson, D.H.L.; Bennett,D. et al. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis. Veterinary Record, v.143, p.219‐223, 1998a.

Coughlan, A.R.; Robertson, D.H.L.; Burke, R. et al. Isolation and Identification of canine Matrix Metalloproteinase‐2 (MMP‐2). Veterinary Record, v.155, p.231‐237, 1998b.

De Rezende, M.U.; De Campos, G.C. A osteoartrite é uma doença mecânica ou inflamatória? Revista Brasileira de Ortopedia, v.48, n.6, p. 471‐474, 2013.

Diegelmann, R.F.; Evans, M.C. Wound healing: An overview of acute, fibrotic and delayed healing. Frontiers in Bioscience, v.9, p.283‐289, 2004.

Dürselen, L.; Claes, L.; Ignatius, A.et al. Comparative animal study of three ligament prostheses for the replacement of the anterior cruciate and medial collateral ligament. Biomaterials, v.17, p.977‐982, 1996.

Englund, M.; Guermazi, A.; Roemer, F.W. et al. Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle‐aged and elderly persons: The Multicenter Osteoarthritis Study. Arthritis & Rheumatology, v.60, p.831‐ 839, 2009.

Ehrenfest, D.M.D; Rasmusson, L.; Albrektsson, T. Classification of platelet concentrates: From pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology, v.27, n.3, p.158‐167, 2008.

Felson,D.T.;Mclaughlin, S.; Goggins, J. et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Annals of Internal Medicine, v.139, n.5, p.330‐336, 2003 (part.1).

Filho, M.M.; Rahal, S.C. O uso de anti‐inflamatórios inibidores Cox‐2 seletivos na osteoartrite canina. Veterinária e Zootecnia, v.15, p. 407‐415, 2008.

Franklin, S.P.; Park, R.D.; Egger, E.L. Metacarpophalangeal and metatarsophalangeal osteoarthritis in 49 dogs. Journal of the American Animal Hospital Association, v.45, p. 112‐117, 2009.

Freymiller, E.G.;Aghaloo, T.L. Platelet‐rich plasma: Ready or not? Journal of Oral and Maxillofacial Surgery, v.62, p.484‐488, 2004.

Froum, S.J.; Wallace, S.S.; Tarnow, D.O. et al. Effect of platelet‐rich plasma on bone growth and osseointegration in human maxillary sinus grafts: Three bilateral case reports. The International Journal of Periodontics & Restorative Dentistry, v.22, n.1, p.41‐54, 2002.

Giraldo, C.E.; López, C.; Alvarez, M.E. et al. Effects of the breed, sex and age on cellular content and growth factor release from equine pure‐platelet rich plasma and pure‐ platelet rich gel. BMC Veterinary Research, v. 9, p. 29‐39, 2013.

Gobbi, G.; Vitale, M. Platelet‐rich plasma preparations for biological therapy: Applications and limits. Operative Techniques in Orthopaedics, v.22, p.10‐15, 2012.

Goh, J.C.; Ouyang, H.W.;Teoh, S.H. et al. Tissue‐engineering approach to the repair and regeneration of tendons and ligaments. Tissue Engineering, v.9, n.1, p.E31‐E44, 2003 (suppl.1).

Guilak, F.; Ratcliffe, A.; Lane, N. et al. Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritis. Journal of Orthopaedic Research, v.12, n.4, p.474‐484, 1994.

Hakimi, M.; Jungbluth, P.; Sager, G. et al. Combined use of platelet‐rich plasma and autologous bone grafts in the treatment of long bone defects in mini‐pigs. Injury, v.41, p.717‐723, 2010.

Harrison, P. Platelet function analysis. Blood Reviews, v.19, p.111‐123, 2005.

Harvey, A.K.; Hrubey, P.S.; Chandrasekhar, S. Transforming growth factor‐beta inhibition of interleukin‐1 activity involves down‐regulation of interleukin‐1 receptors on chondrocytes. Experimental Cell Research, v.195, p.376‐385, 1991.

Henrotin, Y.; Martel‐Pelletier, J.; Msika, P.et al. Usefulness of specific OA biomarkers, Coll2‐1 and Coll2‐1NO2, in the anterior cruciate ligament OA canine model. Osteoarthritis and Cartilage, v.20, p.787‐790, 2012.

Huang, T.F.; Chen, Y.T.; Yang, T.H. et al. Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament. International Society of Cellular Therapy, v.10, n.8, p.806‐814, 2008.

Iacopetti, I.; Perazzi, A.; Ferrari, V. et al. Application of platelet‐rich gel to enhance wound healing in the horse: A case report. Journal of Equine Veterinary Science, v.32, p.123‐128, 2012.

Innes, J.F.; Bacon, D.; Lynch, C. et al. Long‐term outcome of surgery for dogs with cranial cruciate ligament deficiency. Veterinary Record, v.147, p.325‐328, 2000.

Intini, G. The use of platelet‐rich plasma in bone reconstruction therapy. Biomaterials, v.30, p.4956‐ 4966, 2009.

Jennings, L.K. Mechanisms of platelet activation: Need for new strategies to protect against platelet‐mediated atherothrombosis. Thrombosis and Haemostasis, v.102, p.248‐257, 2009.

Jo, C.H.; Kim, J.E.; Yoon, K.S. et al. Platelet‐rich plasma stimulates cell proliferation and enhances matrix gene expression and synthesis in tenocytes from human rotator cuff tendons with degenerative tears. The American Journal of Sports Medicine, v.40, n.5, p.1035‐1045, 2012.

Johnson, J.A.; Austin, C.; Breur, G.J. Incidence of canine appendicular musculoskeletal disorders in 16 veterinary teaching hospitals from 1980 through 1989. Veterinary Compendium Orthopedic Traumatology, v.7, p.56‐59, 1994.

Johnston, S.A. Osteoarthritis: Joint anatomy, physiology, and pathobiology. The Veterinary Clinics of North America Small Animal Practice, v.27, n.4, p.699‐723, 1997.

Joyce, M.E.; Roberts, A.B.; Sporn, M.B. et al. Transforming growth factor‐b and the initiation of chondrogenesis and osteogenesis in the rat femur. The Journal of Cell Biology, v.110, p.2195‐2207, 1990.

Kawakita, K.; Nishiyama, T.; Fujishiro, T. et al. Akt phosphorylation in human chondrocytes is regulated by p53R2 in response to mechanical stress. Osteoarthritis Cartilage, v.20, p.1603‐1609, 2012.

Konttinen, Y.T.; Sillat, T.; Barreto, G. et al. Osteoarthritis as an autoinflammatory disease caused by chondrocyte‐mediated inflammatory responses. Arthritis & Rheumatology, v.64, p.613‐616, 2012.

Kang, H.J.; Kang, E.S. Ideal concentration of growth factors in rabbit’s flexor tendonculture. Yonsei Medical Journal, v.40, n.1, p.26‐29, 1999.

Kon, E.; Filardo, G.; DiMatteo, B. et al. Platelet‐rich plasma in sports medicine: New treatment for tendon and cartilage lesions. Operative Techniques in Orthopaedics, v.22, p.78‐85, 2012.

Lane, N.E.; Lin, P.; Christiansen, L. et al. Association of mild acetabular dysplasia with an increased risk of incident hip osteoarthritis in elderly white women: the study of osteoporotic fractures. Arthritis & Rheumatism, v.43, p.400‐404, 2000.

Lee, A.J.; Chung, W.H.; Kim, D.H. et al. Anterior cruciate ligament reconstruction in a rabbit model using canine small intestinal submucosa and autologous platelet‐rich plasma. Journal of Surgical Research, v.178, p.206‐215, 2012.

Lees, P.; LandonI, M.F.; Giraudel, J. et al. Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology and Therapeutics, v. 27, p. 479‐490. 2004.

Maletius,W.; Messner, K. Eighteen to twenty‐four year follow‐up after complete rupture. American Journal of Sports Medicine, v.27, p.711‐717, 1999.

Marx, R.E. Platelet‐Rich Plasma: Evidence to support its use. Journal of Oral and Maxillofacial Surgery, v.62, p.489‐496, 2004.

Marx, R.E.; Carlson, E.R.; Eichstaedt, R.M. Platelet‐rich plasma growth factor enhancement for bone grafts. Oral Surgery, Oral Medicine, Oral Pathology, v.85, n.6, p.638‐646, 1998.

Matyas, J.R.; Adams, M.E.; Huang, D. et al. Major role of collagen IIB in the elevation of total type II procollagen messenger RNA in the hypertrophic phase of experimental osteoarthritis. Arthritis & Rheumatism, v.40, p.1046‐1049, 1997a.

Matyas, J.R.; Huang, D.; Chung, M. et al. Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis. Arthritis & Rheumatism, v.46 p.1536‐1543, 2002.

Matyas, J.R.; Sandell, L.J.; Adams, M.E. Gene expression of type II collagens in chondro‐ osteophytes in experimental osteoarthritis. Osteoarthritis Cartilage, v.5, p.99‐105, 1997b.

Mazzuco, L.; Balbo, V.; Borzini, P. Platelet‐rich plasma and platelet gel preparation using Plateltex®. Voxsanguinis, v.94, p.202‐208, 2008.

McDevitt, C.A.; Muir, H. Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog. Journal of Bone and Joint Surgery, v.58, p.94‐101, 1976.

Meisterling, S.; Schoderbek, J.R.; Andrews, J.A. Anterior Cruciate Ligament Reconstruction. Operative Techniques in Sports Medicine, v.17, p.2‐10, 2009.

Milano, G.; Sanna‐Passino, E.; Deriu, L. et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: An experimental study in a sheep model. Osteoarthritis and Cartilage, v.18, p.971‐980, 2010.

Mishra, A.; Woodall, J.; Vieira, A. Treatment of tendon and muscle using platelet‐rich plasma. Clinics in Sports Medicine, v.28, p. 113‐125, 2009.

Mobasheri, A.; Henrotin, Y. Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: Mission for the next decade. The Veterinary Journal, v.185, p.95‐97, 2010.

Muzzi, L.A.L.; Rezende, C.M.F.; Muzzi, R.A.L. Fisioterapia após substituição artroscópica do ligamento cruzado cranial em cães. I ‐ avaliação clínica, radiográfica e ultrassonográfica. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, v.61, n.4, p.805‐814, 2009.

Oates, T.W.; Rouse, C.A.; Cochran, D.L. Mitogenic effects of growth factors on human periodontal ligament cells in vitro. Journal of Periodontology, v.64, n.2, p.142‐148, 1993.

Papalia, R.; Del Buono, A. Osti, L. et al. Meniscectomy as a risk factor for knee osteoarthritis: A systematic review. British Medical Bulletin, v.99, p.89‐106, 2011.

Patel, S.; Dhillon, M.S.; Aggarwal, S. et al. Treatment with platelet‐rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double‐blind, randomized trial. The American Journal of Sports Medicine, v.41, n.2, p.356‐364, 2013.

Petrigliano, F.A.; McAllister, D.R.; Wu, B. Tissue Engineering for Anterior Cruciate Ligament Reconstruction: A Review of Current Strategies. Arthroscopy: The Journal of Arthroscopic and Related Surgery, v.22, n.4, p.441‐451, 2006.

Pincus, T. Clinical evidence for osteoarthritis as an inflammatory disease. Current Rheumatology Reports, v.3, p.524‐534, 2001.

Piscoya, J.L.; Fermor, B.; Kraus, V.B. et al. The influence of mechanical compression on the induction of osteoarthritis‐related biomarkers in articular cartilage explants. Osteoarthritis and Cartilage, v.13, p.1092‐1099, 2005.

Ray, A.; Ray, B.K. An inflammation‐responsive transcription factor in the pathophysiology of osteoarthritis. Biorheology, v.45, p.399‐409, 2008.

Rezende, U.M.; Gobbi, R.G. Tratamento medicamentoso da osteoartrose do joelho: drogas modificadoras da doença. Revista Brasileira de Ortopedia, v.44, p.14‐19. 2009.

Roberts, D.E.; Archibald, M.N.; Ratna, B. Mechanism of collagen activation in human platelets. Journal of Biology and Chemistry, v.279, n.9, p.19421‐19430, 2004.

Rodriguez‐Flores, J.; Palomar, M.A.; Torres, J. Plasma rico en plaquetas: fundamentos biológicos y aplicaciones en cirugía maxilofacial y estética facial. Revista Española de Cirugía Oral y Maxilofacial, v.34, n.1, p.8‐17, 2012.

Roemer, F.W.; Guermazi, A.; Felson, D.T. et al. Presence of MRI‐detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30‐ month follow‐up: The MOST study. Annals of the Rheumatic Diseases, v.70, p.1804‐ 1809, 2011.

Rychel, J.K. Diagnosis and Treatment of Osteoarthritis. Topics in Companion Animal Medicine, v.25, n.1, p.20‐25, 2010.

Sanchez, M.; Azofra, J.; Anitua, E. et al. Plasma rich in growth factors to treat an articular cartilage avulsion: A case report. Medicine & Science in Sports & Exercise, v.35, n.10, p.1648‐1652, 2003.

Shinmei, M.; Okada, Y.; Masuda, K. et al. The Mechanism of Cartilage Degradation in Osteoarthritic Joints. Seminars in Arthritis and Rheumatism, v.19, n.4, p.16‐20, 1990.

Silva, R.F. Caracterizações celular e ultra‐estrutural do concentrado de plaquetas em cães e gatos e avaliação do seu efeito na osteoartrose em cães. Belo Horizonte, Brasil: Universidade Federal de Minas Gerais, 2012. 88p. Tese (Doutorado em ciência animal).

Silva, R.F.; Alvarez, M.E.; Rios, D.L. Et al. Evaluation of the effect of calcium gluconate and bovine thrombin on the temporal release of transforming growth factor beta 1 and platelet‐derived growth factor isoform BB from feline platelet concentrates. Veterinary Research, v.8, n.212, 2012a.

Silva, R.F.; Carmona, J.U.; Rezende, C.M.F. Comparison of the effect of calcium gluconato and batroxobin on the release of transforming growth factor beta 1 in canine platelet concentrates. Veterinary Research, v.8, p.121‐127, 2012b.

Silva, R.F.; Carmona, J.U.; Rezende, C.M.F. Ultrastructural characteristics of fibrin clots from canine and feline platelet concentrates activated with calcium gluconate or calcium gluconate plus batroxobin. Veterinary Research, v.9, p.77‐82, 2013.

Silva, R.F.; Rezende, C.M.F; Paes‐Leme, F.O. et al. Evaluacióndel método del tubo para concentrar plaquetas caninas: estudio celular. Archivos de Medicina Veterinaria, v.43, p.95‐98, 2011a.

Silva, R.F; Rezende, C.M.F; Paes‐Leme, F.O. et al. Evaluación del método del tubo para concentrar plaquetas felinas: estudio celular. Archivos de Medicina Veterinaria, v.43, p.187‐190, 2011b.

Smith, S.E.; Roukis, T.S. Bone and wound healing augmentation with platelet‐rich plasma. Clinics in Podiatric Medicine and Surgery, v.26, p.559‐588, 2009.

Sohn, D.H.; Sokolove, J.; Sharpe, O. et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll‐like receptor4. Arthritis Research & Therapy, v.14, n.1, 2012.

Stockwell, R.A. Cartilage failure in osteoarthritis: Relevance of normal structure and function: A review. Clinical Anatomy, v.4,n.3, p.161‐191,1991.

Tatarunas, A.C. Estudo artroscopico das articulações do ombro e do joelho no cão. São Paulo, Brasil: Universidad de São Paulo, 2004. 150f. Dissertação (Doutorado em medicina veterinária).

Textor, J. Autologous biologic treatment for equine musculoskeletal injuries: Platelet‐ rich plasma and IL‐1 receptor antagonist protein. The Veterinary Clinics of North America Equine practice, v.27, n.2, p.275‐298, 2011.

Tiwari, M.;Bhargava, R. Platelet rich plasma therapy: A comparative effective therapy with promising results in plantar fasciitis. Clinical Orthopaedic and Trauma, v.4, p.31‐ 35, 2013.

Tohidnezhad, M.; Varoga, D.; Wruck, C.J. et al. Platelet‐released growth factors can accelerate tenocyte proliferation and activate the anti‐oxidant response element. Histochemistry and Cell Biology, v.135, p.453‐460, 2011.

Tyler, J.A. Insulin‐like growth factor‐1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochemical Journal, v.260, p.543‐ 548, 1989.

Verhamme, P.; Hoylaerts, M.F. Hemostasis and inflammation: Two of a kind? Thrombosis Journal, v.7, n.15, 2009.

Virchenko, O.;Aspenberg, P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Ortopedica, v.77, n.5, p.806‐812, 2006.

Wainer, R.A.; Clarke, T.J.; Poehling, G.G. Arthroscopic Reconstruction of the Anterior Ligament Using Allograft Tendon Cruciate. The Journal of Arthroscopic and Related Surgery, v.4, n.3, p.99‐205, 1998.

Wang, D.S.; Hanamoto, M.; Fang, F. et al. Defibrinogenating effect of batroxobin (Defibrase ®) in rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin‐treated rats in vitro. Atherosclerosis, v.156, p.73‐80, 2001.

Wasterlain, A.S.; Braun, H.J.; Dragoo, J.L. Contents and formulations of platelet‐rich plasma. Operative Techniques in Orthopaedics, v.22, p.33‐42, 2012.

Weibrich, G.; Hansen, T.; Kleis, W. et al. Effect of platelet concentration in platelet‐rich plasma on peri‐implant bone regeneration. Bone, v.34, p.665‐671, 2004.

Wilkerson, M.J.; Shuman, W.; Swist, S. et al. Platelet size, platelet surface‐associated IgG, and reticulated platelets in dogs with immune‐mediated thrombocytopenia. Veterinary Clinical Pathology, v.30, n.3, p.141‐149, 2001.

Witte, M.B.; Barbul, A. General principles of wound healing. Surgical Clinics of North America, v.77, n.3, p.509‐528, 1997.

Xie, X.; Wu, H.; Zhao, S. The effect of platelet‐rich plasma on patterns of gene expression in a dog model of anterior cruciate ligament reconstruction. Journal of Surgical Research, v.180, p.80‐88, 2013a.

Xie, X.; Zhao, S.; Wu, H. et al. Platelet‐rich plasma enhances autograft revascularization and reinnervation in a dog model of anterior cruciate ligament reconstruction. Journal of Surgical Research, v.183, n.1, p.214‐222, 2013b.

Yamaguchi,R.; Tereshima, H.; Yoneyama, S. et al. Effects of platelet‐rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. Journal of Surgical Research, v.173, p.258‐266, 2012.

Descargas

Los datos de descargas todavía no están disponibles.
Sistema OJS - Metabiblioteca |